CD274 and non-small cell lung carcinoma: A study found that for patients with advanced renal cell carcinoma and non-small cell lung cancer, the use of antibiotics within the first 30 days of PD-1/PD-L1 antibody treatment was associated with a decreased survival rate and significantly shorter overall survival 31.